p53 and c-myc alterations in patients with non-small cell lung carcinoma in Serbia

Journal of B.U.ON.

Volumn 9, Issue 1, 2004, Pages 67-72

  Minić, Vesna ^a   Andjelic G ^a   Stanic V ^a   Magic Z ^a  

^a DEPARTMENT OF TOXICOLOGY   (Czech Republic)

Author keywords

c myc gene; Non small cell lung carcinoma; p53 gene; PCR SSCP analysis

Indexed keywords

CHLOROFORM; DNA; MYC PROTEIN; PHENOL; PROTEIN P53;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER STAGING; CONTROLLED STUDY; DNA ISOLATION; EXON; FEMALE; FROZEN SECTION; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; STATISTICAL ANALYSIS; YUGOSLAVIA;

EID: 2442661627     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Toyooka S, Maruyama R, Toyooka K et al. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer 2003; 103: 153-160.
2. Grondin SC, Liptay MJ. Current concepts in the staging of non-small cell lung cancer. Surg Oncol 2002; 11: 181-190.
3. Tomizawa Y, Kohno T, Fujita T et al. Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma. Oncogene 1999; 18: 1007-1014.
4. Fong KM, Sekido Y, Minna JD. Molecular pathogenesis of lung cancer. J Thorac Cardiovasc Surg 1999; 118: 1136-1152.
5. Vahakangas KH, Bennett WP, Castren K et al. p53 and K-ras mutations in lung cancers from former and never-smoking women. Cancer Res 2001; 61: 4350-4356.
6. Anonymous. The World Health Organization Histological Typing of Lung Tumours (2nd edn). Am J Clin Pathol 1982; 77: 123-136.
7. Sambrook J, Fritsch EF, Maniatis T. Preparation of organic reagents. In:Nolan C (ed). Molecular Cloning; a Laboratory Manual (2nd edn). Cold Spring Harbor Laboratory Press, New York, 1989: B4-B5.
8. Sakai E, Rikimaru K, Ueda M et al. The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma. Int J Cancer 1992; 52: 867-872.
9. Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Development 1999; 13: 2658-2669.
10. Richardson GE, Johnson BE. The biology of lung cancer. Semin Oncol 1993; 20: 105-127.
11. Soussi T, Beroud C. Assesing TP53 status in human tumours to evaluate clinical outcome. Nature Rev 2001; 1: 1-8.
12. Huang C, Taki T, Adachi M, Konishi T, Higashyama M, Miyake M. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer. Oncogene 1998; 16: 2469-2477.
13. Hashimoto T, Tokuchi Y, Hayashi M et al. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas. Cancer Res 1999; 59: 5572-5577.
14. Skaug V, Ryberg D, Kure EH et al. p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients. Clin Cancer Res 2000; 6: 1031-1037.
15. Vega FJ, Iniesta P, Caldes T et al. p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer. Br J Cancer 1997; 76: 44-51.
16. Bennett WP, Hussain SP, Vahakangas KH, Khan MA, Shields PG, Harris CC. Molecular epidemiology of human cancer risk: gene-environment interactions and p-53 mutation spectrum in human lung cancer. J Pathol 1999; 187: 8-18.
17. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129-1136.
18. Gorgoulis VG, Zacharatos P, Kotsinas A et al. Human papillomavirus (HPV) is possibly involved in laryngeal but not in lung carcenogenesis. Hum Pathol 1999; 30: 274-283.
19. Clavel CE, Nawrocki B, Bosseaux B et al. Detection of human papillomavirus DNA in bronchopulmonary carcinomas by hybrid capture II: a study of 185 tumors. Cancer 2000; 88: 1347-1352.
20. Cheng YW, Chiou HL, Sheu GT et al. The association of human papillomavirus 16/18 infection with lung cancer among non-smoking Taiwanese women. Cancer Res 2001; 61: 2799-2803.
21. Arango D, Corner GA, Wadler S, Catalano PJ, Augenlicht LH. c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo. Cancer Res 2001; 61: 4910-4915.